The IPO market has been mostly frozen. But a weak market for mergers and acquisitions is also keeping struggling companies ...

Volume, and its relationship with price, is one of the key considerations an investor should always bear in mind. Warren ...

Looking at a May 2025 trial & a $300M price tag, Disney has made a deal with thousands of female employees over their pay ...

tech giant, which is scheduled to report earnings on Nov. 20, have nearly tripled both year-to-date and from a year ago ...

MLB awards finalists were announced yesterday for the MVP, Cy Young, Rookies of the Year, and Managers of the Year in each ...

In a report released today, David Westenberg from Piper Sandler assigned a Hold rating to Elanco Animal Health (ELAN – Research Report), ...

AbbVie Inc. shares fell the most in three years after two mid-stage trials of its drug to treat schizophrenia failed to meet ...

Piper Sandler analyst Clarke Jeffries raised the firm’s price target on Lightspeed (LSPD) to $17 from $15 and keeps a Neutral rating on the shares. Exiting Q2 2025, Lightspeed will be full steam ahead ...

AbbVie said on Monday that an experimental schizophrenia drug it gained through an $8.7 billion deal for Cerevel Therapeutics failed two mid-stage studies, sending the drugmaker's shares plunging 12.5 ...

"A sharply lower new-issuance calendar, peak yields, large redemption money and mutual funds inflows are all positive ...

The regulatory shift could bring some relief to investors after a year in which bank stocks were weighed down by concerns ...

NYU leases 1.1 million square feet at 770 Broadway for 70 years, boosting Vornado's portfolio amid occupancy challenges.